Perspective Therapeutics (CATX) Expected to Announce Quarterly Earnings on Wednesday
Perspective Therapeutics (NYSE:CATX – Get Free Report) will likely be posting its quarterly earnings results after the market ...
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $53.14 Average PT from Brokerages
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) have received a consensus recommendation of “Buy” from the ...
MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Initiated VALUE, a global Phase III pivotal trial of EscharEx® for venous leg ulcersExpanded strategic research collaborations with industry ...
GenSight Biologics Confirms Definitive Full-Year 2024 Consolidated Financial Results Are in Line with Estimates
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...